Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/2014
09/12/2014WO2014138603A1 Stabilization of moisture-sensitive drugs
09/12/2014WO2014138501A2 Compositions and methods for the treatment of skin diseases
09/12/2014WO2014138278A1 Lipid bilayer coated mesoporous silica nanoparticles with a high loading capacity for one or more anticancer agents
09/12/2014WO2014138241A1 Pharmaceuticals for oral delivery
09/12/2014WO2014138186A1 Bioorthogonal two-component delivery systems for enhanced internalization of nanotherapeutics
09/12/2014WO2014138085A1 Thermoresponsive hydrogel containing polymer microparticles for noninvasive ocular drug delivery
09/12/2014WO2014138046A1 Use of agonists of formyl peptide receptor 2 for treating dermatological diseases
09/12/2014WO2014138037A1 Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases
09/12/2014WO2014138018A1 Preservative free bimatoprost and timolol solutions
09/12/2014WO2014137877A1 Dry pharmaceutical compositions comprising active agent nanoparticles bound to carrier particles
09/12/2014WO2014137799A1 Solid compositions comprising a glucokinase activator and methods of making and using the same
09/12/2014WO2014137797A2 Stable glucokinase activator compositions
09/12/2014WO2014137789A1 Novel esterified cellulose ethers of low viscosity and high molecular weight
09/12/2014WO2014137779A1 Novel esterified cellulose ethers of very high molecular weight
09/12/2014WO2014137778A1 Novel esterified cellulose ethers of very low viscosity
09/12/2014WO2014137777A1 Novel esterified cellulose ethers of low viscosity
09/12/2014WO2014137395A1 Salicylic acid gel
09/12/2014WO2014137385A1 Intrathecal hydromorphone solutions having improved stability
09/12/2014WO2014137050A1 Porous microparticles in which trail is surface modified and chemical anticancer drug is incorporated, and preparation method therefor
09/12/2014WO2014136944A1 Aqueous liquid composition including high concentration of l-histidine
09/12/2014WO2014136857A1 Coating composition, coated preparation and method for producing same
09/12/2014WO2014136717A1 Transdermally absorbable pharmaceutical composition
09/12/2014WO2014136494A1 Enteric-coated fine particle and drug composition
09/12/2014WO2014136100A1 Modified poly(beta-amino ester)s for drug delivery
09/12/2014WO2014136079A1 Oral formulations of deferasirox
09/12/2014WO2014136048A1 Formulations of organic compounds
09/12/2014WO2014136038A1 Hard capsule formulation
09/12/2014WO2014136036A1 Nutritional and medicinal oral composition for veterinary use
09/12/2014WO2014136035A1 Nutritional and medicinal oral composition for veterinary use
09/12/2014WO2014135967A1 Curcumin solid lipid particles and methods for their preparation and use
09/12/2014WO2014135965A1 Bismuth liquid filled hard capsules
09/12/2014WO2014135891A1 Pharmaceutical compositions for rectal administration
09/12/2014WO2014135855A1 Condom
09/12/2014WO2014135630A1 Nano-microdelivery systems for oromucosal delivery of an active ingredient
09/12/2014WO2014135572A1 Tablet formulation of a pi3kalpha inhibitor
09/12/2014WO2014135545A1 Solid dispersion comprising amorphous lorcaserin hydrochloride
09/12/2014WO2014135170A1 Novel formula of iron based nanocomposites for rapid and efficient treatment of iron deficiency anemia
09/12/2014WO2014135123A1 17α-ethynyl-androst-5-ene-3β,7β,17β-triol ophthalmic preparation
09/12/2014WO2014134922A1 Meloxicam eye drops and preparation method and use thereof
09/12/2014WO2014134853A1 Proprietary chinese medicine suitable for global tobacco control, preparation method and use thereof
09/12/2014WO2014134797A1 Lipidosome preparation, preparation method and application thereof
09/12/2014WO2014134698A1 Cpg oligonucleotide formulations and methods and uses thereof
09/12/2014WO2014113576A9 Needleless injection device and methods of administering one or more needleless injections to an organ of interest
09/11/2014US20140257189 Microneedle deposition method
09/11/2014US20140257100 Porphyrin Microbubbles
09/11/2014US20140256837 Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use
09/11/2014US20140256810 Low melting propionic acid derivative particles for use in oral dosage forms
09/11/2014US20140256781 Novel Formulation of Indomethacin
09/11/2014US20140256764 Tamper resistant dosage form comprising an adsorbent and an adverse agent
09/11/2014US20140256749 Methods and compositions for transdermal delivery of caffeine in the form of solutions or suspensions
09/11/2014US20140256696 Steroid conjugates
09/11/2014US20140256694 Steroid antibiotic conjugates
09/11/2014US20140256690 Contraceptive method
09/11/2014US20140256688 Topical compositions and methods of treatment of anorectal disorders
09/11/2014US20140256683 Treating disease using compositions for oral administration of zoledronic acid or related compounds
09/11/2014US20140256675 Ophthalmic compositions and methods for treating eyes
09/11/2014US20140256667 Novel treatments for actinic keratoses
09/11/2014US20140256662 Administration of avermectin/milbemycin compounds for the treatment of ophthalmic pathologies
09/11/2014US20140256661 Pharmaceutical compositions for rectal administration
09/11/2014US20140256660 Antibiotic conjugates linked with steroid drugs
09/11/2014US20140256653 Whey protein micelles to enhance muscle mass and performance
09/11/2014US20140256651 Cyclosporine A steroid conjugates
09/11/2014US20140256631 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
09/11/2014US20140256623 Transmucosal delivery of pharmaceutical active substances
09/11/2014US20140256617 In Situ Forming Hydrogel and Method Using Same
09/11/2014US20140256612 Antibiotic conjugates directly linked with steroid drugs
09/11/2014US20140255594 Method of preparing biologically active formulations
09/11/2014US20140255516 Method of using peelable film-forming composition
09/11/2014US20140255505 Pazopanib Formulation
09/11/2014US20140255503 Pharmaceutical composition of omeprazole
09/11/2014US20140255502 Nanoparticle drug carrier, pharmaceutical composition and manufacturing method thereof
09/11/2014US20140255501 Novel Preparation Of An Enteric Release System
09/11/2014US20140255498 Pharmaceutical nanosuspension
09/11/2014US20140255497 Organic Compounds
09/11/2014US20140255496 Micronized placental tissue compositions and methods of making and using the same
09/11/2014US20140255495 Colon lavage system
09/11/2014US20140255494 Novel Formulation of Indomethacin
09/11/2014US20140255493 Extrudate and methods of using said extrudate
09/11/2014US20140255492 Fine dry particulate adenosine compositions and topical formulations including the same
09/11/2014US20140255491 Method and System For the Treatment of Chronic Obstructive Pulmonary Disease With Nebulized Anticholinergic Administrations
09/11/2014US20140255487 Dosage form for insertion into the mouth
09/11/2014US20140255486 Coated Tablet Formulation and Method
09/11/2014US20140255484 Modified release pharmaceutical compositions of dexlansoprazole
09/11/2014US20140255483 Pharmaceutical composition and administrations thereof
09/11/2014US20140255482 Manufacturing Solid Pharmaceutical Dosage Forms With Visible Micro- And Nanostructured Surfaces And Micro- And Nanostructured Pharmaceutical Dosage Form
09/11/2014US20140255481 Pharmaceutical Compositions for Oral Administration of Insulin Peptides
09/11/2014US20140255480 Pharmaceutical formulation of nanonized fenofibrate
09/11/2014US20140255475 Method of lyophilizing liposomes
09/11/2014US20140255474 Composition for Treatment of Inflammatory Disorders
09/11/2014US20140255473 Steroid hormone delivery systems and methods of preparing the same
09/11/2014US20140255472 Pegylated liposomes for delivery of immunogen-encoding rna
09/11/2014US20140255471 Method of treating brain tumors
09/11/2014US20140255470 Multivalent liposome formulations
09/11/2014US20140255469 Use of photolyase for reducing or improving subclinical field cancerization associated with actinic keratosis
09/11/2014US20140255466 Composition for enhancing transdermal absorption of drug and patch preparation
09/11/2014US20140255464 Multi-layer biodegradable device having adjustable drug release profile
09/11/2014US20140255463 Sweet tart energy tablet
09/11/2014US20140255462 Xenotransplant Compositions and Methods of Stroke Therapy
09/11/2014US20140255458 Injectable bulking compositions
09/11/2014US20140255454 Methods of wound care and treatment
1 ... 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 ... 2991